Siren »

Definium Therape shares owned by Siren

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Siren from 13F filings

Historical chart of Siren investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Siren

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 920k 18.90

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Edgewise Therapeutics (EWTX)
BeOne Medicines Sponsored Ads (ONC)
Tango Therapeutics (TNGX)
Bicara Therapeutics (BCAX)
Revolution Medicines (RVMD)
Arrowhead Pharmaceuticals (ARWR)
Veradermics Common Stock (MANE)
Xenon Pharmaceuticals (XENE)
Olema Pharmaceuticals (OLMA)
Crinetics Pharmaceuticals In (CRNX)
Lexicon Pharmaceuticals Com New (LXRX)
Cogent Biosciences (COGT)

View all positions for Siren

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape